The Only Monthly Membership With a Positive ROI!
España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
The Only Monthly Membership With a Positive ROI!
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Juan Spínelli
Central Ohio Cities Postpone Marijuana Sales Despite Statewide Legalization
Ohio's cannabis legalization faces local moratoriums, affecting economic growth and job creation. Discover the impact and future prospects
Medical Cannabis Patients Increased Sixfold In Six Years, Declined In States Where Recreational Use Was Legalized
University of Michigan research reveals a six-fold increase in medical cannabis patients since 2016, with over four million using it for chronic pain relief. However, medical enrollment declined in states where recreational use was legalized.
Accessibility And Legality: Psychedelic's Path A Decade After Colorado's Legalization
Explore the evolving landscape of psychedelics, from the economic potential of psilocybin research to the challenges of legalization..
Nation's First-Ever Psilocybin Edibles Manufacturer License Granted In Oregon
Oregon licenses Spiritus Oregon as the first legal psilocybin edibles manufacturer in the U.S., marking a milestone in the psychedelic industry.
Cannabis And Metabolic Syndrome: A New Piece In The Puzzle
New study reveals cannabis's potential in managing metabolic syndrome, showing significant health benefits and offering new hope in the fight against obesity.
Cannabis Shops Are Selling Like Crazy One Year After Legalization In Maryland, But Black Market Persists
Despite Maryland's thriving legal cannabis market, illicit sales remain strong. Experts discuss the challenges and strategies in combating the persistent black market.
Veterans Groups Urge FDA To Approve MDMA-Assisted Therapy For PTSD As August Decision Looms
Army boots near White House highlight veterans' suicide crisis, as advocates urge the FDA to approve MDMA-assisted therapy for PTSD.
Kentucky's Medical Marijuana Licensing Process Off To A Slow Start Despite Lots Of Interest, Here's Why
Despite high interest, Kentucky's medical cannabis licensing process is moving slowly due partly to financial and regulatory challenges.
Tokey The Bear Joins PTA Mom To Open This New Jersey Town's First Retail Cannabis Shop
Jamie Singer, a PTA mom, opens Boonton's first cannabis shop, Boone Town Provisions, with a grand opening event featuring live music and more.
DEA Faces Backlash Over Psychedelics Ban Proposal From Student Advocacy Group
Student-led group challenges DEA's proposed ban on DOI and DOC, highlighting lack of abuse evidence and potential therapeutic benefits
Minnesota Opens Applications For Cannabis Business Social Equity License Preapproval
Minnesota opens social equity cannabis business license preapproval applications on July 24, with resources and support available online.
Weedmaps And NuggMD Partner To Launch Medical Cannabis Education And Application Program
Weedmaps partners with NuggMD to launch a pilot program that streamlines medical cannabis education and application, enhancing patient access and convenience.
North American Cannabis Companies Are Looking To Germany For Growth Outside Domestic Markets
North American cannabis firms are turning to Germany for growth as they face market challenges at home. Investments surge as Germany decriminalizes marijuana use.
Czech Republic Continues To Push Toward Marijuana Legalization, Will Save Billions In Cannabis Prosecutions
Czechia's cannabis legalization model is taking shape, combining home cultivation, cultivation associations, and a regulated market. Learn more about the country's evolving approach.
Mike Tyson's TYSON 2.0 Introduces Mikeadelics: Simplifying Home Mushroom Cultivation
Tyson 2.0, led by Mike Tyson, launches Mikeadelics, an innovative home-grow mushroom kit, marking Carma HoldCo's entry into the psychedelic industry.
Recovered Alcoholics Using Ayahuasca Face Rejection At AA Meetings
Recovered alcoholics using ayahuasca face rejection at AA meetings, highlighting a rift within the recovery community over psychedelic use for healing.
Google Co-Founder Sergey Brin Pledges $15M To Psychedelics Research Start-Up
Google co-founder Sergey Brin invests $15M in psychedelic biotech Soneira to develop ibogaine for mental health treatment, marking a new trend in Silicon Valley's interest in psychedelics.
HYTN Innovations Acquires Prism Labs To Boost Psychedelic Drug Manufacturing Capabilities
HYTN Innovations Inc. completes the acquisition of Prism Scientific Labs, enhancing its psychedelic compound manufacturing capabilities and expanding its research and development potential.
UCLA's Vision For Psychedelics Therapy: A Rooftop Garden As A Living Laboratory
UCLA plans a groundbreaking rooftop garden for psychedelic-assisted therapy, blending nature and innovation to enhance mental health treatments.
Gov. Newsom Signs Bill To Streamline Psychedelics Research In California Amid Legislative Setbacks
California Governor Gavin Newsom signs a bill to expedite the processing of psychedelics research applications, addressing a significant backlog and advancing the state's scientific studies.